View in EDS HTML Full Text PDF Full Text

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.

Saved in:
Bibliographic Details
Title: Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
Authors: Cuker, Adam1 (AUTHOR) adam.cuker@uphs.upenn.edu, Bass, Ann D2 (AUTHOR), Nadj, Congor3 (AUTHOR), Agius, Mark A4 (AUTHOR), Steingo, Brian5 (AUTHOR), Selmaj, Krzysztof W6 (AUTHOR), Thoits, Timothy7 (AUTHOR), Guerreiro, Alexandre8 (AUTHOR), Van Wijmeersch, Bart9 (AUTHOR), Ziemssen, Tjalf10 (AUTHOR), Meuth, Sven G11 (AUTHOR), LaGanke, Christopher C12 (AUTHOR), Thangavelu, Karthinathan13 (AUTHOR), Rodriguez, Claudio E13,14 (AUTHOR), Baker, Darren P13 (AUTHOR), Margolin, David H13,15 (AUTHOR), Jannsens, Ann16 (AUTHOR)
Source: Multiple Sclerosis Journal. Jan2020, Vol. 26 Issue 1, p48-56. 9p. 1 Diagram, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13524585
DOI:10.1177/1352458518816612